Posted at the Institutional Resources for Unique Collection and Academic Archives at Tokyo Dental College, Available from http://ir.tdc.ac.jp/ Title ���������������������� Author(s) ��, � Journal ����, 117(2): 93-103 URL http://doi.org/10.15041/tdcgakuho.117.93 Right Description
12
Embed
Title ダウン症候群関連骨髄増殖性疾患と造血微小環 …ir.tdc.ac.jp/irucaa/bitstream/10130/4210/1/117_93.pdf94 宮内:ダウン症候群関連骨髄増殖性疾患
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Posted at the Institutional Resources for Unique Collection and Academic Archives at Tokyo Dental College,
キーワード:ダウン症候群,一過性骨髄造血異常症,急性 Jun MIYAUCHI : Myeloid proliferations related to Down syn-巨核芽球性白血病,造血微小環境,GATA1 drome and the hematopoietic microenvironment(Depart-
東京歯科大学市川総合病院臨床検査科 ment of Pathology & Laboratory Medicine, Tokyo Dental(2017年1月27日受付,2017年2月27日受理) College Ichikawa General Hospital)http : //doi.org/10 .15041 /tdcgakuho.117 .93連絡先:〒272 ‐8513 千葉県市川市菅野5-11-13
文 献1)Greaves MF, Maia AT, Wiemels JL, Ford AM : Leuke-mia in twins : lessons in natural history. Blood,102:2321-2333,2003.2)Greaves M : Pre-natal origins of childhood leukemia. Rev Clin Exp Hematol, 7:233-245,2003.3)Gill Super HJ, Rothberg PG, Kobayashi H, Freeman AI, Diaz MO, Rowley JD : Clonal, nonconstitutional rearrange-ments of the MLL gene in infant twins with acute lym-phoblastic leukemia : in utero chromosome rearrangement of11 q23 . Blood,83:641-644,1994.4)Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M : Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood,94:1057-1062,1999.5)Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, Greaves MF : Backtracking leukemia to birth : identification of clonotypic gene fusion sequences in neo-natal blood spots. Proc Natl Acad Sci U S A,94:13950-13954,1997.6)Dzierzak E, Speck NA : Of lineage and legacy : the development of mammalian hematopoietic stem cells. Nat Immunol, 9:129-136,2008.7)Hitzler JK, Zipursky A : Origins of leukaemia in chil-dren with Down syndrome. Nat Rev Cancer, 5:11-20,2005.8)Baumann I, Niemeyer CM, Brunning RD, Arber DA, Porwit A : Myeloid proliferations related to Down syn-drome. WHO Classification of tumours of haematopoietic and lymphoid tissues(Swerdlow SH, Campo E, Harris NL,et al., eds.), pp.142-144 , WHO Press, Geneva,2008.9)Roy A, Roberts I, Norton A, Vyas P : Acute megak-aryoblastic leukaemia(AMKL)and transient myeloprolif-erative disorder(TMD)in Down syndrome : a multi-step model of myeloid leukaemogenesis. Br J Haematol,147:3-12,2009.
10)Zipursky A, Thorner P, De Harven E, Christensen H, Doyle J : Myelodysplasia and acute megakaryoblastic leu-kemia in Down’s syndrome. Leuk Res, 18:163-171,1994.
11)Zipursky A : Transient leukaemia -- a benign form of leu-kaemia in newborn infants with trisomy21 . Br J Haema-tol,120:930-938,2003.
12)Hitzler JK : Acute megakaryoblastic leukemia in Down syndrome. Pediatr Blood Cancer,49:1066-1069,2007.
13)Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H : The
― 15 ―
102 宮内:ダウン症候群関連骨髄増殖性疾患
production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood,75:1540-1548,1990.
14)Roy A, Roberts I, Vyas P : Biology and management of transient abnormal myelopoiesis(TAM)in children with Down syndrome. Semin Fetal Neonatal Med, 17:196-201,2012.
15)Gamis AS, Alonzo TA, Gerbing RB, Hilden JM, Sorrell AD, Sharma M, Loew TW, Arceci RJ, Barnard D, Doyle J, Massey G, Perentesis J, Ravindranath Y, Taub J, Smith FO : Natural history of transient myeloproliferative disor-der clinically diagnosed in Down syndrome neonates : a report from the Children’s Oncology Group Study A2971 . Blood,118:6752-6759;quiz6996,2011.
16)Roberts I, Alford K, Hall G, Juban G, Richmond H, Nor-ton A, Vallance G, Perkins K, Marchi E, McGowan S, Roy A, Cowan G, Anthony M, Gupta A, Ho J, Uthaya S, Cur-ley A, Rasiah SV, Watts T, Nicholl R, Bedford-Russell A, Blumberg R, Thomas A, Gibson B, Halsey C, Lee PW, Go-dambe S, Sweeney C, Bhatnagar N, Goriely A, Campbell P, Vyas P : GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome : identifica-tion of a population at risk of leukemia. Blood,122:3908-3917,2013.
17)Mateos MK, Barbaric D, Byatt SA, Sutton R, Marshall GM : Down syndrome and leukemia : insights into leu-kemogenesis and translational targets. Transl Pediatr,4:76-92,2015.
18)Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I : Transient abnormal myelopoiesis and AML in Down syn-drome : an update. Curr Hematol Malig Rep, 11:333-341,2016.
19)Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, Ravindranath Y, Dahl G, Weinstein HJ ; Chil-dren’s Oncology Group(COG): A prospective study of the natural history of transient leukemia(TL)in neonates with Down syndrome(DS): Children’s Oncology Group(COG)study POG-9481 . Blood,107:4606-4613,2006.20)Miyashita T, Asada M, Fujimoto J, Inaba T, Takihara Y, Sugita K, Bessho F, Furukawa T, Mizutani S : Clonal analysis of transient myeloproliferative disorder in Down’s syndrome. Leukemia, 5:56-59,1991.
21)Kurahashi H, Hara J, Yumura-Yagi K, Murayama N, Inoue M, Ishihara S, Tawa A, Okada S, Kawa-Ha K : Monoclonal nature of transient abnormal myelopoiesis in Down’s syndrome. Blood,77:1161-1163,1991.
22)Zipursky A, Rose T, Skidmore M, Thorner P, Doyle J : Hydrops fetalis and neonatal leukemia in Down syndrome. Pediatr Hematol Oncol,13:81-87,1996.
23)de Tar MW, Dittman W, Gilbert J : Transient myelopro-liferative disease of the newborn : case report with pla-cental, cytogenetic, and flow cytometric findings. Hum Pathol,31:396-398,2000.
24)Lentz SE, Coulson CC, Gocke CD, Fantaskey AP : Pla-cental pathology in maternal and neonatal myeloprolif-erative disorders. Obstet Gynecol,91:863,1998.
25)Smrcek JM, Baschat AA, Germer U, Gloeckner-Hofmann K, Gembruch U : Fetal hydrops and hepatosplenomegaly in the second half of pregnancy : a sign of myeloprolifera-tive disorder in fetuses with trisomy 21 . Ultrasound Ob-stet Gynecol,17:403-409,2001.
26)Hayashi Y, Eguchi M, Sugita K, Nakazawa S, Sato T,
Kojima S, Bessho F, Konishi S, Inaba T, Hanada R, et al. : Cytogenetic findings and clinical features in acute leuke-mia and transient myeloproliferative disorder in Down’s syndrome. Blood,72:15-23,1988.
27)Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD : Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syn-drome. Nat Genet,32:148-152,2002.
28)Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD :Mutations in GATA1 in both transient myeloprolifera-tive disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol Dis, 31:351-356,2003.
29)Groet J, McElwaine S, Spinelli M, Rinaldi A, Burtscher I, Mulligan C, Mensah A, Cavani S, Dagna-Bricarelli F, Basso G, Cotter FE, Nizetic D : Acquired mutations in GATA1 in neonates with Down’s syndrome with tran-sient myeloid disorder. Lancet,361:1617-1620,2003.
30)Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A :GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood,101:4301-4304,2003.
31)Mundschau G, Gurbuxani S, Gamis AS, Greene ME, Arceci RJ, Crispino JD : Mutagenesis of GATA1 is an in-itiating event in Down syndrome leukemogenesis. Blood,101:4298-4300,2003.
32)Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G, Kempski H, Haas OA, Izraeli S : Mutations in exon 2of GATA1 are early events in megakaryocytic malig-nancies associated with trisomy 21 . Blood, 102:981-986,2003.
33)Xu G, Nagano M, Kanezaki R, Toki T, Hayashi Y, Taketani T, Taki T, Mitui T, Koike K, Kato K, Imaizumi M, Sekine I, Ikeda Y, Hanada R, Sako M, Kudo K, Kojima S, Ohneda O, Yamamoto M, Ito E : Frequent mutationsin the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood, 102:2960-2968,2003.
34)Shimada A, Xu G, Toki T, Kimura H, Hayashi Y, Ito E : Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syn-drome. Blood,103:366,2004.
35)Kanegane H, Watanabe S, Nomura K, Xu G, Ito E, Miyawaki T : Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome. Int J Hematol,86:250-252,2007.
36)Gurbuxani S, Vyas P, Crispino JD : Recent insights into the mechanisms of myeloid leukemogenesis in Down syn-drome. Blood,103:399-406,2004.
37)Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O’Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P : Natural history of GATA1 mutations in Down syndrome. Blood,103:2480-2489,2004.
38)Groet J, Mulligan C, Spinelli M, Serra A, McElwaine S, Cotter FE, Dagna-Bricarelli F, Saglio G, Basso G, Nizetic D : Independent clones at separable stages of differentia-tion, bearing different GATA1 mutations, in the same
― 16 ―
103 歯科学報 Vol.117,No.2(2017)
TMD patient with Down syndrome. Blood, 106:1887-1888,2005.
39)Miyauchi J, Ito Y, Kawano T, Tsunematsu Y, Shimizu K : Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down’s syndrome : a report of four autopsy cases and proposal of a hypothesis. Blood,80:1521-1527,1992.
40)Brodeur GM, Dahl GV, Williams DL, Tipton RE, Kalwin-sky DK : Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood,55:691-693,1980.
41)Kalousek DK, Chan KW : Transient myeloproliferative disorder in chromosomally normal newborn infant. Med Pediatr Oncol,15:38-41,1987.
42)Roy A, Cowan G, Mead AJ, Filippi S, Bohn G, Chaidos A, Tunstall O, Chan JK, Choolani M, Bennett P, Kumar S, Atkinson D, Wyatt-Ashmead J, Hu M, Stumpf MP, Goude-venou K, O’Connor D, Chou ST, Weiss MJ, Karadimitris A, Jacobsen SE, Vyas P, Roberts I : Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21 . Proc Natl Acad Sci U S A, 109:17579-17584,2012.
43)Hollanda LM, Lima CS, Cunha AF, Albuquerque DM, Vassallo J, Ozelo MC, Joazeiro PP, Saad ST, Costa FF : An inherited mutation leading to production of only theshort isoform of GATA-1 is associated with impaired erythropoiesis. Nat Genet,38:807-812,2006.
44)Zwaan CM, Reinhardt D, Hitzler J, Vyas P : Acute leu-kemias in children with Down syndrome. Hematol Oncol Clin North Am,24:19-34,2010.
45)Birger Y, Goldberg L, Chlon TM, Goldenson B, Muler I, Schiby G, Jacob-Hirsch J, Rechavi G, Crispino JD, Izraeli S : Perturbation of fetal hematopoiesis in a mouse model of Down syndrome’s transient myeloproliferative disorder. Blood,122:988-998,2013.
46)Yoshida K, Toki T, Okuno Y, Kanezaki R, Shiraishi Y, Sato-Otsubo A, Sanada M, Park MJ, Terui K, Suzuki H, Kon A, Nagata Y, Sato Y, Wang R, Shiba N, Chiba K, Tanaka H, Hama A, Muramatsu H, Hasegawa D, Nakamura K, Kanegane H, Tsukamoto K, Adachi S, Kawakami K, Kato K, Nishimura R, Izraeli S, Hayashi Y, Miyano S, Kojima S, Ito E, Ogawa S : The landscape of somatic mu-tations in Down syndrome-related myeloid disorders. Nat Genet,45:1293-1299,2013.
47)Becroft DM, Zwi LJ : Perinatal visceral fibrosis accom-panying the megakaryoblastic leukemoid reaction of Down syndrome. Pediatr Pathol,10:397-406,1990.
48)Ruchelli ED, Uri A, Dimmick JE, Bove KE, Huff DS, Duncan LM, Jennings JB, Witzleben CL : Severe perinatal liver disease and Down syndrome : an apparent relation-ship. Hum Pathol,22:1274-1280,1991.
49)Arai H, Ishida A, Nakajima W, Nishinomiya F, Yama-zoe A, Takada G : Immunohistochemical study on trans-forming growth factor-beta1 expression in liver fibrosis
of Down’s syndrome with transient abnormal myelopoi-esis. Hum Pathol,30:474-476,1999.
50)Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nakayama H, Hara T : High expression of platelet-derived growth factor and transforming growth factor-β1 in blast cells from patients with Down Syndrome suffering from tran-sient myeloproliferative disorder and organ fibrosis. Br J Haematol,115:472-475,2001.
51)Zhang CC, Lodish HF : Insulin-like growth factor2 ex-pressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood, 103:2513-2521,2004.
52)Pollak M : Insulin and insulin-like growth factor signal-ling in neoplasia. Nat Rev Cancer, 8:915-928,2008.
53)Klusmann JH, Godinho FJ, Heitmann K, Maroz A, Koch ML, Reinhardt D, Orkin SH, Li Z : Developmentalstage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev,24:1659-1672,2010.
54)Miyauchi J, Ito Y, Tsukamoto K, Takahashi H, Ishikura K, Sugita K, Miyashita T : Blasts in transient leukaemia in neonates with Down syndrome differentiate into baso-phil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form ofGATA1. Br J Haematol,148:898-909,2010.
55)Eguchi M, Sakaibara H, Suda J, Ozawa T, Hayashi Y, Sato T, Kojima S, Furukawa T : Ultrastructural and ul-tracytochemical differences between transient myelopro-liferative disorder and megakaryoblastic leukaemia in Down’s syndrome. Br J Haematol,73:315-322,1989.
56)Miyauchi J, Kawaguchi H : Fetal liver stromal cells support blast growth in transient abnormal myelopoiesis in Down syndrome through GM-CSF. J Cell Biochem,115:1176-1186,2014.
57)Wolber EM, Dame C, Fahnenstich H, Hofmann D, Bart-mann P, Jelkmann W, Fandrey J : Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood,94:97-105,1999.
58)Miyauchi J : The role of the hematopoietic microenvi-ronment in the natural course of myeloid proliferations related to Down syndrome. Journal of Tokyo Wemen’s Medical University,84 , Extra : E257-E267,2014.
59)Gamis AS, Hilden JM : Transient myeloproliferative disorder, a disorder with too few data and many unan-swered questions : does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol, 24:2-5,2002.
60)Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, Hows JM, Navarrete C, Greaves M : Chro-mosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci U S A,99:8242-8247,2002.